Big Movers: Xenoport, Inc. (NASDAQ:XNPT), Corindus Vascular Robotics Inc. (NYSEMKT:CVRS), NephroGenex, Inc. (NASDAQ:NRX), Taseko Mines Ltd. (NYSEMKT:TGB),

Research analysts at Credit Suisse started coverage on shares of XenoPort, Inc. (NASDAQ:XNPT) in a research report issued to clients and investors on Tuesday, Market Beat Ratings reports. The brokerage set an “underperform” rating and a $4.00 price target on the biopharmaceutical company’s stock. Credit Suisse’s price target points to a potential downside of 16.49% from the company’s previous close.

Xenoport, Inc. (NASDAQ:XNPT) belongs to Healthcare sector. Its weekly performance is 11.11%. On last trading day company shares ended up at $4.60.

Corindus Vascular Robotics, Inc. (NYSE MKT:CVRS), announced that it will release financial and business results for the fourth quarter and year-end 2015 after the close of trading on Tuesday, March 8, 2016. The Company’s management team will host a corresponding conference call beginning at 4:30 p.m. ET to discuss the financial results and recent business developments.

Corindus Vascular Robotics Inc. (NYSEMKT:CVRS) shares moved up 5.51% in last trading session and ended the day at $1.34. CVRS Gross Margin is -64.00% and its return on assets is -63.40%. Corindus Vascular Robotics Inc. (NYSEMKT:CVRS) quarterly performance is -55.92%.

NephroGenex, Inc. (NASDAQ: NRX) announced that its Board of Directors has made a determination to pause the clinical program of the Company’s product candidate oral Pyridorin® for the treatment of diabetic nephropathy, effect a restructuring of its operations, and implement a strategic transaction. The Board of Directors made this determination in light of the remaining trial costs, the Company’s cash balance and the condition of the capital markets.

On 24 February, NephroGenex, Inc. (NASDAQ:NRX) shares moved down -37.50% and was closed at $0.70. NephroGenex, Inc. (NASDAQ:NRX) year to date (YTD) performance is -56.25%.

Taseko Mines Ltd (NYSE: TGB) reported Q4 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $61.4 million versus the consensus estimate of $79.58 million.

Taseko Mines Ltd. (NYSEMKT:TGB) ended the last trading day at $0.35. Company weekly volatility is calculated as 7.96% and price to cash ratio as 1.14. Taseko Mines Ltd. (NYSEMKT:TGB) showed a weekly performance of -3.47%.

Care.com, Inc. (NYSE: CRCM) Revenue attributable to the US Consumer Business totaled $31.1 million in the fourth quarter of 2015, a 25% increase from $25.0 million in the fourth quarter of 2014. For the year, revenue attributable to the US Consumer Business totaled $115.0 million, a 25% increase from $92.0 million in 2014.

Care.com, Inc. (NYSE:CRCM) shares advanced 3.19% in last trading session and ended the day at $5.50. CRCM Gross Margin is 72.90% and its return on assets is -48.50%. Care.com, Inc. (NYSE:CRCM) quarterly performance is -15.64%.

Leave a Reply

Your email address will not be published. Required fields are marked *